Helsinn and Angelini Pharma sign a partnership agreement globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
The collaboration agreement combines Angelini Pharma's expertise in neurological diseases with JCR Pharmaceuticals' scientific and technological excellence to deliver biotherapeutics across the blood-brain
Rafal Kaminski as Chief Scientific Officer will lead Angelini Pharma's future pipeline development and research and innovation model He previously served as Chief Scientific Officer at OncoAndredi
Angelini Pharma and Lumira Ventures launch the Angelini Lumira Biosciences Fund (ALBF) finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
ONTOZRY® (Cenobamate) Receives European Commission Approval for the Treatment of Drug-Resistant Focal-Onset Seizures in Adults apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.